-10%
RivaXa 10mg Tablet
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation.
:
Out of stock
In stock – ready to ship
Delivery
Inside Dhaka: 1–2 days · Outside Dhaka: 2–4 days
Cash on Delivery
Pay when you receive your order.
Returns
Easy 7-day return & exchange
- Category
- Tablet & Capsules
- Brand
- Square Pharmaceuticals PLC
Product details
RivaXa 10mg Tablet
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.
Interaction
Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in RivaXa exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided.
Contraindications
It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.
Side Effects
The most common side effects of RivaXa have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.
Pregnancy & Lactation
Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.
Precautions & Warnings
Early discontinuation of RivaXa, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events.
Overdose Effects
Overdose of RivaXa may lead to hemorrhage. RivaXa systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for RivaXa is not available. The use of activated charcoal to reduce absorption in case of RivaXa overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.
Therapeutic Class
Oral Anti-coagulants
Storage Conditions
Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.
0 reviews
⭐
No reviews yet
Bought this product? Share your experience to help others.
You may also like
Recently viewed
RivaXa 10mg Tablet
৳250